AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by THOMPSON, R. E.
Right arrow Articles by HECHT, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOMPSON, R. E.
Right arrow Articles by HECHT, R. A.
Agricola
Right arrow Articles by THOMPSON, R. E.
Right arrow Articles by HECHT, R. A.

American Journal of Clinical Nutrition, Vol 7, 311-317, Copyright © 1959 by The American Society for Clinical Nutrition, Inc.

Studies on a Long-acting Vitamin B12 Preparation

ROBERT E. THOMPSON PH.D.1 and ROY A. HECHT M.D.1

1 From the Technical Division, Armour Pharmaceutical Company, Kankakee, Illinois

Vitamin B12 was converted to an insoluble zinc tannate complex. Subcutaneous injection in rats caused continuous absorption and urinary excretion of vitamin B12 for two weeks from a single dose equivalent to 500 µg vitamin B12. A similar dose injected intramuscularly in humans showed urinary excretion of less than 2 per cent of the injected dose. Serum level vitamin B12 was promptly elevated by several times that of control values, and these levels (above control value) were sustained for 28 days or more from the single dose.

Certain implications of these findings are discussed in relation to previous concepts of vitamin B12 therapy. The increased capacity of CZT injection to provide "body pool" vitamin B12 repletion and long-sustained elevated vitamin B12 serum levels makes it possible to study vitamin B12 therapy of a type not attainable with previous preparations of the vitamin, oral or parenteral. Clinical indications and areas for studying the therapeutic potential of CZT are cited.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1959 by The American Society for Nutrition